Tuesday, November 8, 2022

< + > Pembrolizumab: English Regulator Recommends Life-Saving Cancer Drug

Manufactured by MSD, the drug can help shrink “triple negative” tumours.

No comments:

Post a Comment

< + > Bonus Features – June 28, 2026 – Third-party failures disrupt operations at 85% of practices, nearly 60% of nurses say their tech training falls short, plus 27 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...